Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Kensey Nash

This article was originally published in The Gray Sheet

Executive Summary

Kensey Nash: Relaunches 8F Angio-Seal in the European marketplace following a lapse of availability for several months "due to the interruption of production caused by damage from a roof collapse sustained at Kensey Nash's facility during a January snowstorm," the firm says. Angio-Seal, which is designed to seal arterial punctures following cardiac catheterization procedures, gained the CE Mark in September 1995. Kensey Nash received an FDA approvable letter for the device in July 1995...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006094

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel